Yes go figure, I seem to recall another company had a big jump in price a few years back on news of the FDA granting orphan drug. That was without results to compare with a 15 month ongoing remission that coramsine has seen in a stage 4 patient in the target cancer. It was a different cancer though.
Perhaps it will take a while to register.
- Forums
- ASX - By Stock
- fda grants orphan drug to coramsine
SBP
solbec pharmaceuticals limited
Yes go figure, I seem to recall another company had a big jump...
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NRZ
NEURIZER LTD
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online